Market News

CANNABIS AMNESTY PARTNERS WITH TOQi, AURORA CANNABIS TO CREATE ECONOMIC OPPORTUNITY WITH FIRST TOQi FELLOWSHIP

Fellowship Aims to Bring Justice + Equality to Communities Harmed by Cannabis Criminalization; Applications Now Open for Two Summer Interns

TOQi Technologies Ltd ., award-winning creators of elegantly designed cannabis technology products, has partnered with Cannabis Amnesty a not-for-profit organization dedicated to righting the historical wrongs created by cannabis prohibition, to launch the TOQi Fellowship for Cannabis Amnesty . The inaugural Fellows, who will begin their internships during the summer of 2022, will also be supported by Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), a global leader in the medical and recreational cannabis industry, committed to high quality products and access for patients and consumers. This paid internship is designed to create economic opportunities for people from communities harmed by decades of cannabis prohibition while increasing Cannabis Amnesty's capacity to develop groundbreaking advocacy and programming.

Aurora Cannabis Logo (CNW Group/Cannabis Amnesty)

The TOQi Fellowship is a summer internship program running May through August for ambitious individuals who wish to gain experience in advocacy and communications. The two salaried positions will receive mentorship, networking opportunities, and insight into all aspects of the cannabis industry and Cannabis Amnesty's mission to help those harmed by cannabis prohibition.

"People of today should not bear the burden of the laws of yesterday; while the world has changed and we are able to profit from the industry, it is our civic duty to liberate those who do not enjoy this privilege," said Drew Henson , CEO and Founder, TOQi Technologies. "The hard-working and passionate advocates at Cannabis Amnesty have set the stage to right some of these wrongs, and we are honored to support their cause."

"Historically, cannabis laws were unequally enforced by law enforcement in Canada , disproportionately impacting Black, Indigenous and under-resourced communities. Cannabis convictions limit economic opportunities for people from these communities, thus further entrenching systemic racism through poverty and disenfranchisement," said Annamaria Enenajor , Executive Director, Cannabis Amnesty. "We are grateful to TOQi and Aurora Cannabis for their leadership in supporting our efforts to dismantle these economic barriers and look forward to welcoming more cannabis brands to our shared vision of justice and equality in the cannabis industry."

"As a proudly Canadian company, Aurora values our roots in advocating for cannabis record pardons with Cannabis Amnesty. We have a responsibility to those who have been disproportionately impacted and commit to doing our part. Canadians, or anyone for that matter, shouldn't be burdened with a criminal record for a minor, non-harmful act that is no longer a crime," says Miguel Martin , CEO, Aurora Cannabis . "We deeply admire the team at Cannabis Amnesty for their relentless pursuit of fairness and are honoured to be a part of affording others the opportunity to also be a part of this critical cause."

Applicants can visit TOQiFellowship4CA.com for additional information and to apply. Cannabis Amnesty encourages applications from underrepresented communities and those who have been affected by the harms of cannabis prohibition. Applications will be accepted until April 19, 2022 . Companies interested in being an ally and joining the movement for 2023's TOQi Fellowship can contact info@cannabisamnesty.ca .

About TOQi Technologies LTD.
Founded by award-winning designers, TOQi creates purposeful, premium industry leading cannabis consumption technology from their headquarters in Toronto, Ontario . Inspired by the intersection of design and culture, TOQi believes that attention to detail and user experience are of the utmost importance. For more information, visit mytoqi.com. TOQi does not produce, manufacture or distribute cannabis. Not for sale to minors.

About Cannabis Amnesty
Cannabis Amnesty is a registered not-for-profit organization focused on righting the historical wrongs caused by decades of cannabis criminalization, particularly its impact on racialized communities. Since 2018, Cannabis Amnesty has been at the forefront of advocating for justice and fairness on behalf of those who continue to suffer as a result of cannabis convictions. We challenge the stigma of cannabis convictions, lobby the government on behalf of communities harmed by criminalization and champion equity within the cannabis industry. Learn more at www.cannabisamnesty.ca and follow us on Instagram , LinkedIn and Twitter .

About Aurora Cannabis
Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift , San Rafael '71 , Daily Special , and Whistler , as well as CBD brands, Reliva and KG7 . Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at www.auroramj.com and follow us on Twitter and LinkedIn .

Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB" and is a constituent of the S&P/TSX Composite Index.

Cannabis Amnesty Logo (CNW Group/Cannabis Amnesty)

TOQi Technologies Logo (CNW Group/Cannabis Amnesty)

SOURCE Cannabis Amnesty

Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/March2022/28/c3276.html

News Provided by Canada Newswire via QuoteMedia

ACB:CA,ACB
TSXV:FLWR

The Flowr Corporation Among Top Sellers in Ontario

The Flowr Corporation (TSXV:FLWR) was recently featured in an article analyzing sales data for Ontario cannabis companies on the Ontario cannabis store (OCS) during the first two weeks of legalization.

The OCS is an online sales platform and is the only legal place to acquire recreational cannabis in the province of Ontario. The top sellers in the province were Aurora Cannabis (TSX:ACB; NYSE:ACB), responsible for 24 percent of sales, and RedeCan Pharm, with 26 percent of sales. The next four companies ranged between five and ten percent of sales, and included Emblem Corp. (TSXV:EMC,OTCQX:EMMBF), Canopy Growth (TSX:WEED,NYSE:CGC), VIVO Cannabis and Flowr, which was responsible for six percent of sales in the province.

Keep reading...Show less
TSXV:FLWR

The Flowr Corporation Goes Public on the TSXV

The Flowr Corporation (TSXV:FLWR) has announced that it will commence trading today, September 26, on the TSX Venture Exchange under the ticker symbol FLWR.

The company was recently featured in a Forbes article, where the publication addressed the company’s work leading up to the listing. In anticipation of today’s news, the company raised $27 million and took part in a reverse takeover. According to Flowr CEO Vinay Tolia, they will use the momentum from the listing to “focus on executing [their] business plan.”

Keep reading...Show less
TSXV:LABS

OCS Announces New Supply Agreements with Additional Licensed Producers and Accessory Suppliers

The Ontario Cannabis Store (OCS) is dedicated to providing safe and responsible access to recreational cannabis through its online store once it’s legal on October 17. In preparation for October, the OCS has been establishing its wholesale distribution network so they can provide a broad selection of cannabis products in their legal and privately run stores once Ontario puts its regulations in place.

This week the OCS announced that they have signed six more agreements with licensed producers, bringing their total to 32 licensed producers and 10 accessory suppliers. Of the licensed producers signed, MediPharm Labs Inc. was one of them. MediPharm Labs is a leading B2B Canadian cannabis extractor that produces pharma-grade cannabis oil and concentrates for cannabinoid derived products. Their state-of-the-art facility can currently process 100,000 kilograms of dry cannabis per year and the company plans on increasing its capacity to over 250,000 kilograms per year by Q4 2018. MediPharm Labs has secured a steady supply of cannabis to process from several licensed producers including the James E. Wagner Cultivation Corporation (TSXV:JWCA) and 6779264 Manitoba Ltd. (O/A Bonify).

Keep reading...Show less
Tinley's Announces Plans for Own-Brand Expansion to Accelerate Revenue Growth

Tinley's Announces Plans for Own-Brand Expansion to Accelerate Revenue Growth

Provides Corporate Updates

The Tinley Beverage Company Inc. (CSE: TNY) (OTCQB: TNYBF) ("Tinley's" or the "Company") is pleased to provide updates on Company initiatives aimed to achieve revenue growth through the expansion of the Tinley's and Beckett's brands.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Centurion Provides Project Review and 2023 Plans; Announces Private Placement

Centurion Minerals Ltd. (TSXV: CTN) ("Centurion", or the "Company") wishes to summarize its 2022 achievements and provide an overview of its Canadian gold exploration project, 2023 plans, and objectives, as follows:

  1. Casa Berardi West Gold Project Acquisition: Proceeding with its original focus of acquiring and advancing gold exploration projects, the Company executed an Option Agreement in August 2022 to acquire a 100% interest in the Casa Berardi West Gold Project (the "Project"). The Project consists of 3 claim groups (Noseworthy, Newman and Hepburn) comprising a total of 4,700 hectares, strategically located northeast of Cochrane, Ontario, Canada in the mineral endowed central north Abitibi greenstone belt.

A NI 43-101 Technical Report outlining the Project's historical activities has been completed and can be found on the Company's website. (Casa Berardi West - Centurion Minerals Ltd).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

TerrAscend Closes on Acquisition of High-Performing Dispensary in Maryland

The 10,000 square foot Allegany Medical Marijuana Dispensary is located in Northwest Maryland within six miles of both the West Virgina and Pennsylvania borders

The acquisition complements TerrAscend's fully operational, state-of-the-art 150,000 square foot cultivation and processing facility in Hagerstown, MD and expands the Company's retail footprint to 32 dispensaries nationwide

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less
cannabis plants with bitcoin

Cannabis Weekly Round-Up: Software Firm Pivots to Bitcoin Mining

In a surprising move, enterprise software firm Akerna (NASDAQ:KERN), which has developed programs to aid the cannabis industry, will merge with a Bitcoin miner and sell its software business to POSaBIT Systems (CSE:PBIT,OTCQX:POSAF).

Also this week, a Canadian cannabis operator received a warning from a leading exchange for its low trading numbers.

Keep reading to find out more cannabis highlights from the past five days.

Keep reading...Show less

Curaleaf Announces Launch of Adult-Use Cannabis Sales at Stamford, CT Dispensary

Stamford is Curaleaf's first dispensary in Connecticut to serve adult-use consumers

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has been approved by the Connecticut Department of Consumer Protection to commence adult-use sales at its Stamford, Connecticut location, beginning Saturday, January 28 at 10:00 a.m. Curaleaf Stamford, located at 814 East Main St, is the Company's first dispensary in the state to open its doors to adult-use customers.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Trulieve Opening Medical Marijuana Dispensary in Winter Haven, FL

New dispensary expands patient access to medical cannabis; grand opening specials available

Trulieve Cannabis Corp. (CSE: TRUL )(OTCQX: TCNNF ) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the United States today announced the opening of a new medical dispensary in Winter Haven, Florida . Located at 6000 Cypress Gardens Blvd., the doors will open at 9 a.m. on Saturday, January 28 with ongoing regular hours of 9 a.m. 9 p.m. from Monday through Saturday and 10 a.m. 8 p.m. on Sunday .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×